FDA concluded that based on the available evidence, that the supply of semaglutide meets or exceeds current demand, and that, based on our best judgment looking at the available information with its limitations, supply will meet or exceed projected demand. FDA acknowledges in the Declaratory Order that: [E]ven when a shortage is considered resolved, patients and prescribers may still see intermittent localized supply disruptions as products move through the supply chain from the manufacturer and distributors to local pharmacies
This is a significant development for obesity treatment access, says Christine Bonarrigo, PharmD, a clinical pharmacist at Tufts Medical Center in Boston
Heart 90e44
Ask your doctor about prescription medications: In some cases, you may need a prescription for neuromodulators or secretagogues, especially if you have IBS
Common Injection Mistakes to Avoid In our years of supporting individuals through their weight loss journeys, we have noticed a few common errors that can lead to frustration
